Herantis Pharma Plc's directed share issue
Herantis Pharma Plc's directed share issue Herantis Pharma PlcCompany release 9 November 2017, 7:00 pm Not for publication or distribution, directly or indirectly, in or into Australia, South Africa, Hong Kong, Japan, Canada or the United States of America or in any other jurisdiction in which publishing or distributing would be prohibited by applicable law The Board of Directors of Herantis Pharma Plc (the "Company") has today decided on a directed share issue of 800,000 new shares in aggregate at a per-share subscription price of EUR 5.85 to certain institutional investors and